Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia
β Scribed by Rondeau, Eric
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 40 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Rat PC12 pheochromocytoma cells treated with nerve growth factor (NGF) extend βneuritesβ and initiate a neuronal differentiation pathway. Although neurotrophins, growth factors [e.g., epidermal growth factor (EGF)], and other ligands induce many common primary response genes (PRGs) in P
## Abstract The involvement of the urokinaseβtype plasminogen activator (uPA) system in particular has been extensively studied in the pathogenesis of cancer. The molecular role of the uPA receptor (uPAR) is well characterized with its participation in cell migration and extracellular matrix (ECM)
## Abstract Metastatic growth and invasion by colon cancer cells in the liver requires the ability of the cancer cells to interact with the new tissue environment. Plasmin(ogen) is activated on cell surfaces by urokinaseβtype PA (uPA), and is regulated by uPAR and plasminogen activator inhibitorβ1
The generation of the broad specificity serine protease plasmin in the pericellular environment is regulated by binding of the urokinase-type plasminogen activator (uPA) to its specific glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor, uPAR. This interaction potentiates the reciproc